SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Bill Wexler's Profits of DOOM -- Ignore unavailable to you. Want to Upgrade?


To: Bill Wexler who wrote (4460)2/16/1999 11:46:00 AM
From: taxikid  Respond to of 4634
 
bill, i disagree, but not 100%... in a thinly traded issue the amount of big block buys can sometimes find a savvy investor a nice little trade. some of my best day trade gains were in smaller caps that had abnormal liquidity on little news. The chart doesn't guarantee the roi, but those little spikes can make a good detective some money...
be well
taxi



To: Bill Wexler who wrote (4460)2/16/1999 6:39:00 PM
From: Bill Wexler  Read Replies (1) | Respond to of 4634
 
The Able telecom fraud announces a disaster:

biz.yahoo.com

<<Revenues for Able's fiscal year ended October 31, 1998 are $217.5 million with net income of $2.5 million. After taking into account a non-cash charge to retained earnings of $8.0 million related to the beneficial conversion privileges on preferred stock, other non-recurring adjustments associated with Able's obtaining financing for a portion of the purchase price of MFS Network Technologies, and preferred stock dividends, the loss applicable to common shareholders is $5.8 million, or $0.59 per share. On a diluted basis, the loss applicable to common shareholders is $5.3 million, or $0.51 per share. Able is currently analyzing the effects of the year-end adjustments on previously reported quarterly earnings.>>



To: Bill Wexler who wrote (4460)2/16/1999 6:42:00 PM
From: Bill Wexler  Read Replies (1) | Respond to of 4634
 
The Zonagen fraud announces losses and zero sales of its ineffective drug.

biz.yahoo.com

No matter how many times they squeeze this crud, no matter how many time the whores at Oppenheimer issue phony reports, this stock will eventually and inevitably trade in the low single digits.